Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment Tập 9 Số 2 - Trang 385-450 - 2021
Jamie Burgess, Maryam Ferdousi, David Gosal, Cheng Boon, Keīichi Matsumoto, Anne Marshall, Tony Wing Chung Mak, Andrew Marshall, Bernhard Frank, Rayaz A. Malik, Uazman Alam
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study - 2016
Véronique Dièras, Thomas Bachelot, Mario Campone, Nicolás Isambert, Florence Joly, Christophe Le Tourneau, Philippe Cassier, Emmanuelle Bompas, P. Fumoleau, Sabine Noal, C. Orsini, Marta Jimenez, Diane Charlotte Imbs, Étienne Chatelut
Abstract Introduction To determine the feasibility, maximum-tolerated dose
(MTD), and dose-limiting toxicities (DLT) of pazopanib in combination with
cisplatin. Methods Patients with advanced malignancies were included in a 3 + 3
dose-escalation phase I study. Pazopanib administration started 8 days before
the first infusion of cisplatin; some patients were treated according to a
reverse sequence ... hiện toàn bộ